VOR BIOPHARMA INC (VOR) Stock Income Statement
NASDAQ:VOR - US9290331084 - Common Stock
2 USD
-0.08 (-3.85%)
2.0099 USD
+0.01 (+0.5%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 367.40M | 121.19M | 126.04M | 93.42M | 69.02M | |||
| Research and Development | 335.37M | 93.31M | 94.31M | 64.55M | 47.53M | |||
| Selling, General, and Administrative Expenses | 32.03M | 27.88M | 31.72M | 28.87M | 21.49M | |||
| Operating Income | -367.40M | -121.19M | -126.04M | -93.42M | -69.02M | |||
| Interest Income/Expense | -1.30B | 4.27M | 8.17M | 1.32M | 120.00K | |||
| Income Before Taxes | -1.66B | -116.91M | -117.86M | -92.09M | -68.90M | |||
| Net Income | -1.66B | -116.91M | -117.86M | -92.09M | -70.13M | |||
| EBITDA | -362.82M | -117.66M | -122.54M | -90.89M | -67.59M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -13.66 | -1.70 | -1.75 | -2.33 | -2.10 | |||
| Non GAAP EPS | -3.29 | -1.70 | -1.76 | -2.34 | -2.15 | |||
| Statistics | ||||||||
All data in USD